VERA Company Profile and Key Details
Vera Therapeutics, Inc.
VERA Stock Price Chart
Stock Price Today
Vera Therapeutics, Inc. (VERA) stock surged +0.21%, trading at $33.77 on NASDAQ, up from the previous close of $33.70. The stock opened at $33.52, fluctuating between $33.11 and $34.10 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Company Information
| Employees | 82 |
| Beta | 1.02 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Vera Therapeutics, Inc. (NASDAQ: VERA) stock price is $33.77 in the last trading session. During the trading session, VERA stock reached the peak price of $34.10 while $33.11 was the lowest point it dropped to. The percentage change in VERA stock occurred in the recent session was 0.21% while the dollar amount for the price change in VERA stock was $0.07.
The NASDAQ listed VERA is part of Biotechnology industry that operates in the broader Healthcare sector. Vera Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Tad Thomas Ph.D.
Senior Vice President and Head of Product Devel. & Manufacturing
Mr. Julien E. Capers J.D.
Vice President & Head of Legal
Dr. Joanne Curley Ph.D.
Chief Devel. Officer
Ms. Lauren Frenz
Chief Bus. Officer
Dr. Celia Lin M.D.
Chief Medical Officer
Dr. Neeraj Pakala M.B.A., Ph.D.
Senior Vice President and Head of Product Devel. & Manufacturing
Mr. Tom Doan
Senior Vice President of Devel. Operations
Mr. Joseph R. Young M.B.A.
Senior Vice President of Fin. & Chief Accounting Officer
Dr. Marshall Fordyce M.D.
Founder, Pres, Chief Executive Officer & Director
Ms. Kelly Rauber
Vice President & Head of HR
Mr. Sean P. Grant M.B.A.
Chief Financial Officer
VERA's closing price is 100.53% higher than its 52-week low of $16.84 where as its distance from 52-week high of $51.61 is -34.57%.
Number of VERA employees currently stands at 82.
Official Website of VERA is: https://veratx.com
VERA could be contacted at phone 650 770 0077 and can also be accessed through its website. VERA operates from 8000 Marina Boulevard, Brisbane, CA 94005, United States.
VERA stock volume for the day was 583.6K shares. The average number of VERA shares traded daily for last 3 months was 803.05K.
The market value of VERA currently stands at $2.14B with its latest stock price at $33.77 and 63.32M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com